These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16355549)

  • 1. Hemoglobin response and improvements in quality of life in anemic children with cancer receiving myelosuppressive chemotherapy.
    Hinds PS; Hockenberry M; Feusner J; Hord JD; Rackoff W; Rozzouk BI
    J Support Oncol; 2005; 3(6 Suppl 4):10-1. PubMed ID: 16355549
    [No Abstract]   [Full Text] [Related]  

  • 2. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N; Sriuranpong V; Suwanrusme H
    J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy.
    Osterborg A; Brandberg Y
    Cancer; 2003 Jun; 97(12):3125-6; author reply 3126-7. PubMed ID: 12784351
    [No Abstract]   [Full Text] [Related]  

  • 4. Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy.
    Razzouk BI; Hord JD; Hockenberry M; Hinds PS; Feusner J; Williams D; Rackoff WR
    J Clin Oncol; 2006 Aug; 24(22):3583-9. PubMed ID: 16877725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
    Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
    Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level.
    Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
    Oncologist; 2006 Feb; 11(2):206-16. PubMed ID: 16476841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients previously transfused or treated with epoetin alfa at low baseline hemoglobin are at higher risk for subsequent transfusion: an integrated analysis of the Canadian experience.
    Quirt I; Kovacs M; Couture F; Turner AR; Noble M; Burkes R; Dolan S; Plante RK; Lau CY; Chang J
    Oncologist; 2006 Jan; 11(1):73-82. PubMed ID: 16401716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvements in quality of life associated with epoetin alfa treatment are clinically, as well as statistically, significant.
    Curr Med Res Opin; 2005; 21 Suppl 2():S3-5. PubMed ID: 15969858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patients.
    Puglisi F; Deroma L; Russo S; Cartenì G; Sporchia A; Ucci G; De Signoribus G; Del Prete S; Vecchione A; Pinotti G; Beccaglia P
    Crit Rev Oncol Hematol; 2009 Feb; 69(2):175-82. PubMed ID: 18774730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilisation review of epoetin alfa in cancer patients at a cancer centre in Singapore.
    Chan A; Lim LL; Tao M
    Singapore Med J; 2009 Apr; 50(4):365-70. PubMed ID: 19421679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single institutional experience: is epoetin alpha effective in anemic children with cancer?
    Yilmaz D; Cetingül N; Kantar M; Oniz H; Kansoy S; Kavakli K
    Pediatr Hematol Oncol; 2004; 21(1):1-8. PubMed ID: 14660300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies.
    Straus DJ; Testa MA; Sarokhan BJ; Czuczman MS; Tulpule A; Turner RR; Riggs SA
    Cancer; 2006 Oct; 107(8):1909-17. PubMed ID: 16977654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-weekly epoetin beta therapy in patients with solid tumours and chemotherapy-induced anaemia: a randomized, double-blind, dose-finding study.
    Heras P; Kritikos K; Hatzopoulos A; Mitsibounas D
    Eur J Cancer Care (Engl); 2008 Nov; 17(6):619-23. PubMed ID: 18707619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suboptimal hemoglobin levels: do they impact patients and their therapy? Audience responses.
    Ludwig H; Pecorelli S
    Semin Oncol; 2000 Apr; 27(2 Suppl 4):18-9. PubMed ID: 10847304
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
    Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
    Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy.
    Schouwink JH; Codrington H; Sleeboom HP; Kerkhofs LG; Wormhoudt LW
    Eur J Cancer; 2008 Apr; 44(6):819-29. PubMed ID: 18343652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical benefits of once-weekly epoetin alfa in anemic patients with colorectal cancer receiving chemotherapy.
    Chu E; Einhorn LH; Lefebvre P
    J Support Oncol; 2006 May; 4(5):243-50. PubMed ID: 16724648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating anaemia with epoetin alfa is associated with improvements in quality of life in cancer patients receiving chemotherapy.
    Curr Med Res Opin; 2005; 21 Suppl 2():S9-11. PubMed ID: 15969860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and quality of life outcomes of epoetin-alpha in a double-blind, placebo-controlled, multicentre study of cancer patients receiving non-platinum-containing chemotherapy.
    Littlewood TJ
    Front Radiat Ther Oncol; 2002; 37():34-7. PubMed ID: 11764665
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcomes and predicting response in anaemic chemotherapy patients treated with epoetin alfa. A multicentre, 4-month, open-label study in Australia and New Zealand.
    Bell D; Grimes D; Gurney H; Dalley D; Blackwell T; Fox R; Jeffery M
    Intern Med J; 2008 Oct; 38(10):751-7. PubMed ID: 19143877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.